[On vestibular lesions following treatment with preparations of the streptomyces antibiotic group].
D002648:Child; D004096:Dihydrostreptomycin Sulfate / Q000009:adverse effects; D006311:Hearing Disorders / Q000139:chemically induced; D006801:Humans; D007612:Kanamycin / Q000009:adverse effects*; D007759:Labyrinth Diseases / Q000139:chemically induced*; D008297:Male; D009355:Neomycin / Q000009:adverse effects*; D011704:Pyelonephritis / Q000188:drug therapy; D013307:Streptomycin / Q000009:adverse effects*; D014722:Vestibule, Labyrinth
D007612:Kanamycin; D009355:Neomycin; D004096:Dihydrostreptomycin Sulfate; D013307:Streptomycin
Uber Vestibularisschäden nach Behandlung mit Präparaten der Streptomycesgruppe.